Lotus Pharmaceutical Co., Ltd. (TPE: 1795)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
253.00
-2.50 (-0.98%)
Oct 11, 2024, 1:30 PM CST

Lotus Pharmaceutical Company Description

Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system diseases.

The company also provides over-the-counter products. In addition, it engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services.

Further, the company offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization.

The company has strategic partnership with NRX Pharmaceuticals. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.

Lotus Pharmaceutical Co., Ltd.
Lotus Pharmaceutical logo
Country Taiwan
Founded 1966
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,099
CEO Petar Vazharov

Contact Details

Address:
No. 277 Song Ren Road
Taipei, 110
Taiwan
Phone 886 2 2700 5908
Website lotuspharm.com.tw

Stock Details

Ticker Symbol 1795
Exchange Taiwan Stock Exchange
Fiscal Year January - December
Reporting Currency TWD
ISIN Number TW0001795003
SIC Code 2834

Key Executives

Name Position
Petar Antonov Vazharov Chief Executive Officer and Director
Zenon Zdunek Vice President of Supply Chain and Operations
Eeling Chan Chief Financial Officer
Gwen Hsieh Chief Information Officer
Yu-Ying Yang Associate Director of Co-Operate Communication
Boon Chong Tan Deputy General Manager
Edin Buljubasic Vice President
Yingming Yue Vice President
Valerie Lau Chief Commercial Officer-APAC
Manish Chawla Vice President of Research and Development